CTNNA2 and laryngeal carcinoma: The decreased expression of CTNNA2 in tumors from our poor responders supports a pro-metastatic role for miR-223 as CTNNA2 acts as a tumor suppressor in both endometrial and laryngeal carcinomas (67, 68).